JIN-A02, a fourth-generation, highly effective tyrosine kinase inhibitor with intracranial activity, targeting EGFR C797S mutations in NSCLC

0 277

Cited 0 times in

DC Field	Value	Language
dc.date.accessioned	2023-06-02T00:59:48Z	-
dc.date.available	2023-06-02T00:59:48Z	-
dc.date.issued	2022-09	-
dc.identifier.issn	0923-7534	-
dc.identifier.uri	https://ir.ymlib.yonsei.ac.kr/handle/22282913/194577	-
dc.description.statementOfResponsibility	restriction	-
dc.language	English	-
dc.publisher	Oxford University Press	-
dc.relation.isPartOf	ANNALS OF ONCOLOGY	-
dc.rights	CC BY-NC-ND 2.0 KR	-
dc.title	JIN-A02, a fourth-generation, highly effective tyrosine kinase inhibitor with intracranial activity, targeting EGFR C797S mutations in NSCLC	-
dc.type	Article	-
dc.contributor.college	College of Medicine (의과대학)	-
dc.contributor.department	Others	-
dc.contributor.googleauthor	M.R. Yun	-
dc.contributor.googleauthor	M.R. Yu	-
dc.contributor.googleauthor	K.B. Duggirala	-
dc.contributor.googleauthor	K. Lee	-
dc.contributor.googleauthor	S.M. Lim	-
dc.contributor.googleauthor	A. Jo	-
dc.contributor.googleauthor	E. Seah	-
dc.contributor.googleauthor	C. Kim	-
dc.contributor.googleauthor	B.C. Cho	-
dc.identifier.doi	10.1016/j.annonc.2022.07.1125	-
dc.relation.journalcode	J00171	-
dc.identifier.eissn	1569-8041	-
dc.identifier.url	https://www.sciencedirect.com/science/article/pii/S0923753422029763	-
dc.citation.volume	33	-
dc.citation.number	Supplement 7	-
dc.citation.startPage	S1010	-
dc.citation.endPage	S1011	-
dc.identifier.bibliographicCitation	ANNALS OF ONCOLOGY, Vol.33(Supplement 7) : S1010-S1011, 2022-09	-

Appears in Collections:: 1. College of Medicine (의과대학) > Others (기타) > 1. Journal Papers

Show simple item record Find it @ YMLIB

YUHSpace: JIN-A02, a fourth-generation, highly effective tyrosine kinase inhibitor with intracranial activity, targeting EGFR C797S mutations in NSCLC